Total Payments
$25,948
2024 Payments
$370.46
Companies
22
Transactions
69
Medicare Patients
8,683
Medicare Billing
$3.2M
Payment Breakdown by Category
Consulting$9,940 (38.3%)
Other$9,100 (35.1%)
Food & Beverage$5,601 (21.6%)
Travel$1,307 (5.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,940 | 5 | 38.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $9,100 | 2 | 35.1% |
| Food and Beverage | $5,601 | 60 | 21.6% |
| Travel and Lodging | $1,307 | 2 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Carl Zeiss Meditec, Inc. | $9,436 | 4 | $0 (2020) |
| Genentech USA, Inc. | $6,263 | 13 | $0 (2024) |
| Genentech, Inc. | $5,833 | 7 | $0 (2019) |
| Alcon Vision LLC | $608.77 | 7 | $0 (2023) |
| Alcon Laboratories Inc | $502.38 | 4 | $0 (2018) |
| Johnson & Johnson Surgical Vision, Inc. | $478.87 | 5 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $377.16 | 5 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $342.75 | 3 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $285.76 | 3 | $0 (2017) |
| Sight Sciences, Inc. | $273.01 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $370.46 | 6 | Genentech USA, Inc. ($162.66) |
| 2023 | $674.93 | 6 | Astellas Pharma US Inc ($203.45) |
| 2022 | $692.15 | 8 | Alcon Vision LLC ($440.58) |
| 2021 | $6,087 | 7 | Genentech USA, Inc. ($5,951) |
| 2020 | $9,100 | 2 | Carl Zeiss Meditec, Inc. ($9,100) |
| 2019 | $6,465 | 17 | Genentech, Inc. ($5,709) |
| 2018 | $983.40 | 8 | Alcon Laboratories Inc ($275.82) |
| 2017 | $1,575 | 15 | Johnson & Johnson Surgical Vision, Inc. ($345.28) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/12/2024 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $45.71 | General |
| 05/01/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $145.34 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/24/2024 | Astellas Pharma Global Development | Izervay (Drug) | Food and Beverage | In-kind items and services | $132.87 | General |
| Category: Ophthalmology | ||||||
| 04/11/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/05/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/27/2023 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $122.08 | General |
| Category: Ophthalmology | ||||||
| 11/17/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/24/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $81.37 | General |
| 06/20/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $178.29 | General |
| 05/07/2023 | Alcon Vision LLC | LenSx (Device) | Food and Beverage | In-kind items and services | $147.46 | General |
| Category: Ophthalmology | ||||||
| 01/18/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Ophthalmology | ||||||
| 11/17/2022 | Alcon Vision LLC | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $120.73 | General |
| Category: Glaucoma | ||||||
| 10/01/2022 | Sight Sciences, Inc. | OMNI(R) SURGICAL SYSTEM (US) (Device) | Food and Beverage | In-kind items and services | $137.61 | General |
| Category: Ophthalmology | ||||||
| 09/30/2022 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $145.83 | General |
| Category: Ophthalmology | ||||||
| 09/30/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $89.20 | General |
| Category: TEPEZZA | ||||||
| 04/21/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/12/2022 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: Ophthalmology | ||||||
| 02/22/2022 | Alcon Vision LLC | AcrySof IQ PanOptix UV IOL (Device) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Ophthalmology | ||||||
| 02/09/2022 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $141.72 | General |
| Category: Ophthalmology | ||||||
| 12/07/2021 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $660.00 | General |
| 11/04/2021 | Genentech USA, Inc. | SUSVIMO (Drug) | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/23/2021 | Sight Sciences, Inc. | OMNI(R) SURGICAL SYSTEM (US) (Device) | Food and Beverage | In-kind items and services | $135.40 | General |
| Category: Ophthalmology | ||||||
| 10/16/2021 | Genentech USA, Inc. | Lucentis (Biological) | Consulting Fee | Cash or cash equivalent | $1,980.00 | General |
| Category: Ophthalmology | ||||||
| 09/29/2021 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,320.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 2,367 | 12,021 | $2.8M | $939,390 |
| 2022 | 15 | 2,248 | 6,109 | $2.5M | $829,954 |
| 2021 | 12 | 1,837 | 3,535 | $1.9M | $626,946 |
| 2020 | 16 | 2,231 | 4,764 | $2.4M | $831,956 |
Total Patients
8,683
Total Services
26,429
Medicare Billing
$3.2M
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 117 | 654 | $801,150 | $440,037 | 54.9% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 37 | 6,962 | $382,910 | $203,307 | 53.1% |
| 67028 | Injection of drug into eye | Office | 2023 | 233 | 829 | $607,640 | $76,614 | 12.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 508 | 631 | $148,664 | $59,326 | 39.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 288 | 691 | $110,705 | $49,268 | 44.5% |
| 92134 | Imaging of retina | Office | 2023 | 678 | 1,458 | $554,186 | $47,273 | 8.5% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 99 | 336 | $50,400 | $24,616 | 48.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 174 | 174 | $55,263 | $21,429 | 38.8% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 14 | 15 | $64,791 | $8,493 | 13.1% |
| 92250 | Photography of the retina | Office | 2023 | 179 | 226 | $65,079 | $7,028 | 10.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 11 | 11 | $2,822 | $1,307 | 46.3% |
| 67515 | Injection of drug or substance into membrane covering eyeball | Facility | 2023 | 29 | 34 | $6,231 | $691.94 | 11.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 127 | 710 | $869,750 | $505,491 | 58.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 238 | 763 | $559,264 | $69,802 | 12.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 448 | 581 | $136,884 | $53,340 | 39.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 297 | 686 | $109,904 | $49,270 | 44.8% |
| 92134 | Imaging of retina | Office | 2022 | 639 | 1,397 | $531,000 | $45,106 | 8.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 14 | 1,261 | $69,350 | $37,630 | 54.3% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 111 | 309 | $35,892 | $22,648 | 63.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 150 | 150 | $47,592 | $18,542 | 39.0% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2022 | 16 | 17 | $73,429 | $10,595 | 14.4% |
| 92250 | Photography of the retina | Office | 2022 | 126 | 149 | $42,906 | $4,679 | 10.9% |
| 66682 | Suture of iris and lens | Facility | 2022 | 13 | 14 | $24,430 | $4,451 | 18.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 23 | 23 | $8,791 | $3,674 | 41.8% |
| 66985 | Insertion of prosthetic lens | Facility | 2022 | 11 | 11 | $29,777 | $3,646 | 12.2% |
About Sarah Read
Sarah Read is a Ophthalmology healthcare provider based in Aiea, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2012. The National Provider Identifier (NPI) number assigned to this provider is 1124381652.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Read has received a total of $25,948 in payments from pharmaceutical and medical device companies, with $370.46 received in 2024. These payments were reported across 69 transactions from 22 companies. The most common payment nature is "Consulting Fee" ($9,940).
As a Medicare-enrolled provider, Read has provided services to 8,683 Medicare beneficiaries, totaling 26,429 services with total Medicare billing of $3.2M. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Student in an Organized Health Care Education/Training Program, Ophthalmology
- Location Aiea, HI
- Active Since 06/19/2012
- Last Updated 09/18/2018
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1124381652
Products in Payments
- Lucentis (Biological) $9,946
- CIRRUS HD-OCT (Device) $9,237
- AcrySof (Device) $359.97
- Tecnis 1-piece IOL (Device) $345.28
- Constellation (Device) $291.66
- OMNI(R) SURGICAL SYSTEM (US) (Device) $273.01
- STELLARIS PC (Device) $257.66
- Izervay (Drug) $254.95
- Rhopressa (Drug) $235.25
- ZEISS CATARACT SUITE MARKERLESS (Device) $198.40
- Non-Covered Product (Drug) $162.84
- Vabysmo (Drug) $162.66
- EYLEA HD (Biological) $154.22
- ACTHAR (Biological) $152.60
- XIIDRA (Drug) $149.99
- LenSx (Device) $147.46
- ARGOS (Device) $145.83
- EYLEA (Biological) $141.14
- Tecnis Multifocal Family of 1-piece IOLS (Device) $133.59
- Iluvien (Biological) $125.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Aiea
Gregg Kokame
Ophthalmology — Payments: $206,877
Ophthalmology $206,877
William Wong, M.d, M.D
Ophthalmology — Payments: $39,744
Ophthalmology $39,744
James Lai, M.d, M.D
Ophthalmology — Payments: $10,334
Ophthalmology $10,334
Dr. Raymond Wee, Md, MD
Ophthalmology — Payments: $9,365
Ophthalmology $9,365
Dr. Kenneth Lee, M.d, M.D
Ophthalmology — Payments: $3,320
Ophthalmology $3,320
Dr. Anthony Martyak, M.d, M.D
Ophthalmology — Payments: $2,329
Ophthalmology $2,329